Latest Science - Technology parks biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Is Animal Drug Testing Replaceable?

by CYTES BIOTECHNOLOGIES, SL.

4 years ago
Hepatocytes, Biotechnology

Industry trends in the replacement of in-vivo models

CNAG-CRG will participate in the 2021 edition of the Collider program

by Centre for Genomic Regulation

4 years ago
CNAG-CRG, The Collider program

A team from the Centro Nacional de Análisis Genómico (CNAG-CRG), part of the Centre for Genomic Regulation (CRG), will take part in the 2021 edition of The Collider program, an initiative run by the...

The Pectus Up, an extrathoracic implant for the correction of the Pectus Excavatum, is consolidated in the area of the Colombian Caribbean Coast

by Ventura Medical Technologies

4 years ago
Pectus Excavatum, Pectus Up, congenital deformity, chest cavity

Pectus Excavatum is the most common congenital deformity of the chest cavity. It is defined by a depression of the sternum that gives a sunken appearance to the chest. The condition is diagnosed in ne...

Does the MDR mean the end of the equivalence route for clinical evaluations?

by AKRN Scientific Consulting

4 years ago
clinical safety, clinical investigations, MDR

In Europe, medical device manufacturers with products on the market have long used clinical data from equivalent devices to confirm the clinical safety and performance of their devices. Using clinical...

Desarrollan un nuevo método de etiquetado de bases de ADN para secuenciación

by Universitat Rovira i Virgili

4 years ago
electroquímica, ADN

Este sistema, que permite una instrumentalización más sencilla y asequible y un análisis más rápido, podrá utilizarse para secuenciar ADN mediante detección electroquímica

Artificial intelligence identifies the tiger mosquito from the photos received in the Mosquito Alert app

by UPF - Universitat Pompeu Fabra

4 years ago
Artificial intelligence, Mosquito Alert app

Artificial intelligence, combined with citizen science, will provide real-time detection of the tiger mosquito on a large scale and, as a result, will allow faster control of this disease transmitter....

360º interview with our Medical Device Manager, Talyta Carteano

by Asphalion

4 years ago
Medical Devices

I am a medical device professional with R&D and regulatory background and over 10 years’ experience in the field of Medical Devices, combining a technical background with a fulfilling career in the ...

La insuficiencia cardiaca, detectada a partir de la saliva

by DiCYT - Agencia Iberoamericana para la Difusión de la Ciencia y la Tecnología

4 years ago
chip biosensor, nanopartículas magnéticas, biomarcadores, insuficiencia cardiaca, saliva, sistemas microelectrónicos

El funcionamiento se basa en un chip biosensor y nanopartículas magnéticas que detectan biomarcadores de la insuficiencia cardiaca en la saliva

The brain can teach artificial intelligence a lesson or two: the neural mechanism of autonomous learning uncovered by researchers at IBEC

by IBEC - Institut de Bioenginyeria de Catalunya

4 years ago
artificial intelligence, neuroscience

Cells are more resilient to environmental changes than previously thought

by IRB Barcelona - Instituto de Investigación Biomédica

4 years ago
Cells, environmental changes

The first study to evaluate how environmental conditions affect the genetic program underlying cellular survival, led by the University of Toronto, involves the collaboration of the Structural Bioinfo...

The Pectus Up lands at a new hospital in the community of Madrid in Spain

by Ventura Medical Technologies

4 years ago
Pectus Up, Pectus Excavatum, thoracic surgery

Hospital Infanta Elena joins the hospitals in the Community of Madrid that rely on Pectus Up for the surgical correction of Pectus Excavatum.

3P Biopharmaceuticals and Buzzard Pharmaceuticals start a collaboration to develop a new treatment to combat solid tumours

by 3PBIOVIAN

4 years ago
3P Biopharmaceuticals, Buzzard Pharmaceuticals, cancer indications

3P Biopharmaceuticals and Buzzard Pharmaceuticals have entered into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra, a recombinant protein for cancer indications.